Why this small cap biotech has rocketed 2,511% in the last 5 months

The Zoono Group Ltd (ASX: ZNO) share price has rocketed 22% higher so far today, taking 5-month returns to a phenomenal 2,585%.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Zoono Group Ltd (ASX: ZNO) share price has rocketed 22% higher so far today. Zoono has seen very strong share price growth since last September, and particularly since the outbreak of the coronavirus.

The Zoono share price was sitting at just $0.072 in September last year and has since shot all the way up to $1.88 at the time of writing – a phenomenal 2,511% increase.

Zoono is a global biotech company that is involved in the development, manufacture and global distribution of a unique range of long-lasting and environmentally friendly antimicrobial solutions. The company currently has a market capitalization of $307 million.

Following the coronavirus outbreak, Zoono commented that there has been a high interest in Zoono's technology given its proven efficacy against viruses and bacteria, and ability to prevent cross-contamination.

Recently, Zoono reported unaudited revenues for the quarter so far to 10 February 2020 of NZ$2.4 million, with on-line sales in Australia and New Zealand contributing strongly.

a woman

Announcement in response to coronavirus

On 30 January 2020, Zoono announced to the market its confidence of being well-positioned to be part of the solution to both coronavirus and other new virus threats. The company believes that its Zoono technology, particularly its longevity and killing methodology, delivers an ideal solution.

At this time, the company stated that Zoono's Z71 Microbe Shield Surface Sanitiser was successfully tested in 2014 against bovine coronavirus (a surrogate recognised by the World Health Organisation for other members of the coronaviridae family, including the MERS virus). Test results confirmed a 99.99% efficacy in five minutes.

Zoono's Z71 Microbe Shield Surface Sanitiser and GermFree24 Hand Sanitiser products were recently sent to a German laboratory for testing against the latest Chinese strain of the coronavirus (2019-nCoV).

Operationally, once the impact of the new coronavirus emerged, Zoono made an immediate decision in early January to ramp up production of its key active ingredients and its Z71 Microbe Shield Surface Sanitiser and GermFree24 Hand Sanitiser finished goods.

Recent agreement for Chinese childcare & hotel sectors

A week ago, on February 10, Zoono announced it had entered into an exclusive distribution agreement with Beijing Youmeng Technology and Development Limited for the childcare and hotel sectors in China.

At this time, Zoono had received an initial payment of NZD$775,000 from Beijing Youmeng Technology and Development Limited.

Zoono commented that this agreement in the childcare and hotel sectors in China is another step in Zoono's strategy to focus on specific sectors and on the appointment of reputable distributors with explicit expertise in these market segments.

Zoono also pointed out that it has sought to exercise greater control over the activities and performance of its distributors in its new distribution arrangements.

This agreement is the fourth distribution agreement entered into by the company for an industry sector in the Chinese market in the last six months.

Motley Fool contributor Phil Harpur has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A group of happy young people watching sport on a laptop celebrate.
Share Gainers

Here are the top 10 ASX 200 shares today

It was an exceptional session for investors today.

Read more »

Smiling young parents with their daughter dream of success.
Broker Notes

Why Life360 shares could be dirt cheap and set to rise 90%

Bell Potter has good things to say about this tech stock.

Read more »

a surprised investor reading about an asx share price in a newspaper
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ASX board.
Share Market News

The ASX just hit a rare milestone. Here's what it means for your money

ASX trading activity surges as futures volumes hit record highs.

Read more »

A woman looks nervous and uncertain holding a hand to her chin while looking at a paper cut out of a plane that she's holding in her other hand.
Travel Shares

Qantas stock is down 17.7% in a month. Time to buy?

Qantas is back to April prices.

Read more »

A young man clasps his hand to his head with a pained expression on his face and a laptop in front of him.
Share Fallers

Why Amplitude Energy, Atlas Arteria, Computershare, and Woodside shares are falling today

These shares are falling on hump day. But why?

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Broker Notes

Why this buy-rated ASX mining share is tipped to surge 112%

A leading broker expects this ASX mining share to more than double investors’ money in a year.

Read more »

Excited couple celebrating success while looking at smartphone.
Share Gainers

Why 4DMedical, Brazilian Rare Earths, Clarity, and Tuas shares are racing higher today

These shares are having a better day than most on hump day.

Read more »